KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 104 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $48,802,352 | +23.4% | 2,809,577 | 0.0% | 0.28% | +22.7% |
Q2 2023 | $39,558,844 | +31.3% | 2,809,577 | +0.4% | 0.23% | +39.6% |
Q1 2023 | $30,123,449 | -28.2% | 2,799,577 | 0.0% | 0.16% | -34.9% |
Q4 2022 | $41,937,663 | +16.7% | 2,799,577 | 0.0% | 0.25% | +7.2% |
Q3 2022 | $35,947,000 | +32.5% | 2,799,577 | 0.0% | 0.24% | +52.6% |
Q2 2022 | $27,128,000 | -2.5% | 2,799,577 | 0.0% | 0.15% | -3.8% |
Q1 2022 | $27,828,000 | -15.5% | 2,799,577 | 0.0% | 0.16% | 0.0% |
Q4 2021 | $32,951,000 | +3.3% | 2,799,577 | 0.0% | 0.16% | +14.3% |
Q3 2021 | $31,887,000 | -18.2% | 2,799,577 | 0.0% | 0.14% | -18.1% |
Q2 2021 | $38,998,000 | -24.7% | 2,799,577 | 0.0% | 0.17% | -24.0% |
Q1 2021 | $51,820,000 | +4.8% | 2,799,577 | 0.0% | 0.22% | +21.0% |
Q4 2020 | $49,469,000 | +15.3% | 2,799,577 | 0.0% | 0.19% | +8.8% |
Q3 2020 | $42,890,000 | -39.9% | 2,799,577 | 0.0% | 0.17% | -45.7% |
Q2 2020 | $71,333,000 | +64.6% | 2,799,577 | 0.0% | 0.32% | +18.0% |
Q1 2020 | $43,337,000 | +40.0% | 2,799,577 | 0.0% | 0.27% | +61.8% |
Q4 2019 | $30,963,000 | +30.0% | 2,799,577 | 0.0% | 0.16% | +1.9% |
Q3 2019 | $23,824,000 | -37.1% | 2,799,577 | 0.0% | 0.16% | -37.2% |
Q2 2019 | $37,906,000 | -30.0% | 2,799,577 | -6.7% | 0.26% | -25.6% |
Q1 2019 | $54,180,000 | -35.7% | 3,000,000 | 0.0% | 0.35% | -49.7% |
Q4 2018 | $84,270,000 | +10.2% | 3,000,000 | 0.0% | 0.69% | +36.9% |
Q3 2018 | $76,500,000 | +47.0% | 3,000,000 | 0.0% | 0.50% | +28.9% |
Q2 2018 | $52,050,000 | – | 3,000,000 | – | 0.39% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |